Emerging role of ABC transporters in glia cells in health and diseases of the central nervous system

M Villa, J Wu, S Hansen, J Pahnke - Cells, 2024 - mdpi.com
ATP-binding cassette (ABC) transporters play a crucial role for the efflux of a wide range of
substrates across different cellular membranes. In the central nervous system (CNS), ABC …

New insights into the mechanism of resistance to lenvatinib and strategies for lenvatinib sensitization in hepatocellular carcinoma

FM Fan, JS Fleishman, J Chen, ZS Chen… - Drug Discovery Today, 2024 - Elsevier
Lenvatinib is a multikinase inhibitor that suppresses vascular endothelial growth factor
receptor (VEGFR), fibroblast growth factor receptor (FGFR), platelet-derived growth factor …

Deep behavioural phenoty** of the Q175 Huntington disease mouse model: effects of age, sex, and weight

ET Koch, J Cheng, D Ramandi, MD Sepers, A Hsu… - BMC biology, 2024 - Springer
Background Huntington disease (HD) is a neurodegenerative disorder with complex motor
and behavioural manifestations. The Q175 knock-in mouse model of HD has gained recent …

Medicinal polypharmacology: exploration and exploitation of the polypharmacolome in modern drug development

SM Stefan, M Rafehi - Drug Development Research, 2024 - Wiley Online Library
At the core of complex and multifactorial human diseases, such as cancer, metabolic
syndrome, or neurodegeneration, are multiple players that cross‐talk in robust biological …

[HTML][HTML] Evaluation of cerebrospinal fluid (CSF) and interstitial fluid (ISF) mouse proteomes for the validation and description of Alzheimer's disease biomarkers

AM Górska, I Santos-García, I Eiriz, T Brüning… - Journal of Neuroscience …, 2024 - Elsevier
Background Mass spectrometry (MS)-based cerebrospinal fluid (CSF) proteomics is an
important method for discovering biomarkers of neurodegenerative diseases. CSF serves as …

Medicinal polypharmacology—a scientific glossary of terminology and concepts

SM Stefan, M Rafehi - Frontiers in Pharmacology, 2024 - frontiersin.org
Medicinal polypharmacology is one answer to the complex reality of multifactorial human
diseases that are often unresponsive to single-targeted treatment. It is an admittance that …

Time-and sex-dependent effects of fingolimod treatment in a mouse model of Alzheimer's disease

P Bascuñana, M Brackhan, L Möhle, J Wu, T Brüning… - Biomolecules, 2023 - mdpi.com
Alzheimer's disease (AD) is the most common cause of dementia. Fingolimod has previously
shown beneficial effects in different animal models of AD. However, it has shown …

[HTML][HTML] Diffusion MRI marks progressive alterations in fiber integrity in the zQ175DN mouse model of Huntington's disease

N Vidas-Guscic, J Van Rijswijk, J Van Audekerke… - Neurobiology of …, 2024 - Elsevier
Huntington's disease (HD) is a progressive neurodegenerative disease affecting motor and
cognitive abilities. Multiple studies have found white matter anomalies in HD-affected …

The big data challenge–and how polypharmacology supports the translation from pre-clinical research into clinical use against neurodegenerative diseases and …

SM Stefan, M Rafehi - Neural Regeneration Research, 2024 - journals.lww.com
Sven Marcel Stefan*,#, Muhammad Rafehi*,# aspects that need to be met before publication
of an article. However, these standards must not be confounded with general scientific …

A collaborative network analysis for the interpretation of transcriptomics data in Huntington's disease

O Ozisik, NS Kara, T Abbassi-Daloii, M Térézol… - Scientific Reports, 2025 - nature.com
Rare diseases may affect the quality of life of patients and be life-threatening. Therapeutic
opportunities are often limited, in part because of the lack of understanding of the molecular …